Foreign Drug Pricing E.O. Comments Sought

Posted 5/29/25

The USTR has issued a request for public comments on foreign government policies that may result in U.S. patients covering a disproportionate share of global pharmaceutical research and development costs.

The request is issued pursuant to Executive Order 14297, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, signed by the President on May 12, 2025.

This item is available in full to subscribers.

Please log in to continue

Log in